Navigation Links
AMERIGROUP Reports Q3 Net Income of $22.5 Million or $0.43 per Diluted Share
Date:10/30/2009

VIRGINIA BEACH, Va., Oct. 30, 2009 /PRNewswire-FirstCall/ -- AMERIGROUP Corporation (NYSE: AGP) today announced that net income for the third quarter of 2009 was $22.5 million, or $0.43 per diluted share, versus $37.9 million, or $0.71 per diluted share, for the third quarter of 2008. Third quarter earnings are in line with the preliminary earnings range that the Company issued on October 26, 2009, and reflect elevated medical costs associated with the onset of what appears to be a severe flu season due to the H1N1 virus.

Highlights include:

  • Membership increased 55,000 members, or 3.2%, to approximately 1.8 million from the second quarter of 2009.
  • Total revenues were $1.3 billion, a 1.0% increase over the second quarter of 2009.
  • Health benefits expenses were 87.5% of premium revenues.
  • Selling, general and administrative expenses were 6.3% of total revenues.
  • Cash flow provided by operations was $72.6 million for the three months ended September 30, 2009.
  • Unregulated cash and investments were $277.2 million as of September 30, 2009.
  • Medical claims payable as of September 30, 2009 totaled $550.1 million compared to $563.0 million, as of June 30, 2009.
  • The Company repaid the remaining $18.0 million of outstanding debt under its Credit Agreement and the debt to total capital ratio decreased to 19.8%, as of September 30, 2009, from 20.8%, as of June 30, 2009.
  • The Company repurchased approximately 1.4 million shares of its common stock during the third quarter for $34.3 million.
  • On August 28, 2009, the Company notified the Florida Agency for Health Care Administration of its intent to exit Broward County, effective December 1, 2009, for the Temporary Aid to Needy Families (TANF) Medicaid population.
  • On October 15, 2009, the Company notified the State of Ohio of its intent to exit the Aged, Blind and Disabled (ABD) program in the Southwest Region, effective in the first quarter of 2010. The Company will continue to provide services in the Southwest and West Central regions of Ohio for the TANF Medicaid population.
  • On October 23, 2009, the Company settled litigation regarding the purchase of certain assets related to the New Jersey Medicaid business of University Health Plans, Inc. (UHP). Under the terms of the settlement, the parties dismissed the litigation and the Company's New Jersey subsidiary will purchase certain UHP assets. The Company expects the purchase, which is subject to regulatory approval, to close during the first quarter of 2010.

"At our investor day in September, we discussed how outpatient services continued to be the primary factor driving our higher than expected costs in the third quarter, and said that we expected this trend to continue at least through the end of 2009," said James G. Carlson, AMERIGROUP Chairman and Chief Executive Officer. "More recently, we are seeing a significant spike in flu-related activity which is most prevalent in our southern states. The onset of what appears to be a severe flu season due to the H1N1 virus is the single most important driver of the increase in medical costs over the last 30 days."

Carlson continued, "We believe the H1N1 flu, like the recession, will eventually fade. Over the longer term, we believe that there are a number of reasons to feel good about our future, including the sizable expansion plans in healthcare reform and the ability to improve the delivery of long-term care services. We believe that AMERIGROUP is very well-positioned to capitalize on these opportunities."

Premium Revenues

Premium revenues for the third quarter of 2009 increased 20.2% to $1.3 billion compared to $1.1 billion in the third quarter of 2008. Sequentially, premium revenues increased $14.1 million, or 1.1%, compared with the second quarter of 2009. The sequential increase primarily reflects membership gains in the TANF population across most markets partially offset by increased accruals for the experience rebate in Texas.

In October, the Company received final confirmation of its rate increase in Georgia, which is retroactive to July 1, 2009. The retroactive value of approximately $3.0 million was not booked in the third quarter of 2009. The Company expects to recognize the retroactive portion of the rate increase associated with the third quarter in the fourth quarter of 2009.

Investment Income and Other Revenues

Third quarter investment income and other revenues were $5.3 million versus $17.6 million in the third quarter of 2008 and compared to $6.5 million in the second quarter of 2009. Investment income declined slightly on a sequential basis due to a decrease in yields.

Health Benefits

Health benefits expenses, as a percent of premium revenues, were 87.5% for the third quarter of 2009 versus 82.0% in the third quarter of 2008, and compared to 85.9% in the second quarter of 2009.

The third quarter health benefits ratio is elevated due to ongoing increases in outpatient medical costs. As the Company discussed at its September 2009 investor day, outpatient costs began increasing at higher trend rates relative to historical experience in the first quarter. As expected, the higher trends appear to have continued into the third quarter. Some of the primary drivers include increases in emergency room services, ambulatory surgery and physician services. In contrast, inpatient hospital costs have remained stable and within the Company's expected range.

In addition to higher general trends in outpatient costs, the Company believes that the health benefits ratio was elevated further in the third quarter due to a significant spike in flu-related activity that primarily impacted the Company's Medicaid and CHIP members. As health officials have noted, the H1N1 virus is particularly virulent among children, pregnant women and other high-risk population groups, and this demographic represents approximately 87% of the Company's 1.8 million members.

Based on a combination of indicators, such as prescription information, claims paid for services delivered in September, and various public health statistics, the Company believes that the impact from the H1N1 flu accelerated in a pronounced fashion during September. While the precise quantification of the flu impact in the third quarter remains highly estimated at this point due to the normal lag time in claim payments, information available to the Company indicates flu is a significant contributor to the upward movement in the health benefits ratio.

Additionally, the Company did not record revenue during the third quarter for the annual rate increase in Georgia, as noted in the Premium Revenues section above. This contributed to a higher health benefits ratio than otherwise would have been the case.

The Company experienced favorable reserve development across most markets in the third quarter. However, the impact to the health benefits ratio from the favorable reserve development was neutralized by increased accruals for the Texas experience rebate associated with prior periods, as noted in the Premium Revenues section above.

Selling, General and Administrative Expenses

Selling, general and administrative expenses were 6.3% of total revenues for the third quarter of 2009, versus 10.2% in the third quarter of 2008, and compared to 7.5% for the second quarter of 2009. The selling, general and administrative expense ratio decreased sequentially, due to a reduction in variable compensation accruals as a result of lower operating results.

Premium Taxes

Third quarter premium taxes were $38.3 million versus $23.9 million for the third quarter of 2008, and compared to $34.6 million in the second quarter of 2009. The sequential increase in premium taxes was primarily due to an increase in the premium tax rate in Tennessee, effective July 1, 2009.

Balance Sheet and Cash Flow Highlights

Cash and investments at September 30, 2009 totaled $1.4 billion of which $277.2 million was unregulated.

During the quarter, the Company repurchased approximately 1.4 million shares of its common stock for $34.3 million under the Company's ongoing stock repurchase program. In addition, the Company repaid the remaining $18.0 million of outstanding debt under its Credit Agreement. The debt to total capital ratio decreased to 19.8%, as of September 30, 2009, from 20.8%, as of June 30, 2009.

Medical claims payable as of September 30, 2009 totaled $550.1 million compared to $563.0 million as of June 30, 2009. Days in claims payable represented 45 days of health benefits expense, which is within the expected range of 45 to 55 days, compared to 46 days in the previous quarter. Claims processing speed increased slightly during the quarter, further reducing claims inventory levels. This change was commensurate with the one day decline in days in claims payable.

Included on page 10 is a table presenting the components of the change in medical claims payable for the nine months ended September 30, 2009 and the year ended December 31, 2008.

Cash Flow Highlights

Cash flow provided by operations totaled $106.6 million for the nine months ended September 30, 2009 and $72.6 million for the three months ended September 30, 2009.

Outlook

The Company withdrew its annual earnings guidance for the current year on October 26, 2009 due to the wide range of medical cost outcomes that may occur in the fourth quarter.

Third Quarter Earnings Call

AMERIGROUP senior management will discuss the Company's third quarter results on a conference call Friday, October 30, 2009 at 7:30 a.m. Eastern Time (ET). The conference can be accessed by dialing 866-260-3161 (domestic) or 706-679-7245 (international) approximately ten minutes prior to the start time of the call. A recording of the call may be accessed by dialing 800-642-1687 (domestic) or 706-645-9291 (international) and providing passcode 34392568. The replay will be available shortly after the conclusion of the call until Friday, November 6, 2009 at 11:59 p.m. Eastern Time. The conference call will also be available through the investors' page of the Company's web site, www.amerigroupcorp.com, or through www.earnings.com. A 30-day replay of this webcast will be available on these web sites beginning approximately two hours following the conclusion of the live broadcast earnings conference call.

About AMERIGROUP Corporation

AMERIGROUP Corporation and its subsidiaries help those in publicly funded healthcare programs by ensuring that these individuals enter an organized system of care and a true medical home. Serving approximately 1.8 million members in 11 states nationwide, AMERIGROUP accepts all eligible people regardless of age, sex, race or disability. The Company's product offerings do not utilize any individual underwriting nor deny coverage due to pre-existing medical conditions. AMERIGROUP is dedicated to offering real solutions that improve healthcare access and quality for its members, while proactively working to reduce the overall cost of care to taxpayers. For more information and real story examples of these solutions, please visit www.amerigroupcorp.com

Forward-Looking Statements

This release is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the Securities and Exchange Commission's Fair Disclosure Regulation. This release contains certain ''forward-looking'' statements related to medical costs, our future and our position to capitalize on certain opportunities, which are subject to numerous factors, many of which are outside of our control, including the severity of the flu season and the impact of the H1N1 virus, medical expense trend levels, our ability to manage our medical costs generally, seasonality of health benefits expenses, the levels and amounts of membership, revenues, organic premium revenues, rate increases, operating cash flows, health benefits expenses, selling, general and administrative expenses, days in claims payable, income tax rates, cash balances, earnings per share, net income growth, healthcare reform, interest rates, and our ability to improve the delivery of long-term care services. These statements are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties that may cause our actual results in future periods to differ materially from those projected or contemplated in the forward-looking statements. These risks and uncertainties include, but are not limited to, national, state and local economic conditions, including their effect on the rate-setting process and timing of payments; the effect of government regulations and changes in regulations governing the healthcare industry; changes in Medicaid and Medicare payment levels and methodologies; liabilities and other claims asserted against us; our ability to attract and retain qualified personnel; our ability to maintain compliance with all minimum capital requirements; the availability and terms of capital to fund acquisitions and capital improvements; the competitive environment in which we operate; our ability to maintain and increase membership levels; demographic changes; increased use of services, increased cost of individual services, epidemics, pandemics; the introduction of new or costly treatments and technology; new mandated benefits; insured population characteristics and seasonal changes in the level of healthcare use; our ability to enter into new markets or remain in existing markets; our inability to operate new products and markets at expected levels, including, but not limited to, profitability, membership and targeted service standards; changes in market interest rates or any disruptions in the credit markets; catastrophes, including acts of terrorism or severe weather; and the unfavorable resolution of new or pending litigation.

Investors should also refer to our annual report on Form 10-K for the year ended December 31, 2008 filed with the Securities and Exchange Commission ("SEC") and subsequent quarterly reports on Form 10-Q and current reports on Form 8-K filed with or furnished to the SEC, for a discussion of certain known risk factors that could cause our actual results to differ materially from our current estimates. Given these risks and uncertainties, we can give no assurances that any forward-looking statements will, in fact, transpire and, therefore, caution investors not to place undue reliance on them. We specifically disclaim any obligation to update or revise any forward-looking statements, whether as a result of new information, future developments or otherwise.

                     AMERIGROUP CORPORATION AND SUBSIDIARIES
                 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                  (dollars in thousands, except per share data)
                                   (unaudited)

                                 Three months ended      Nine months ended
                                   September 30,           September 30,
                                   -------------           -------------
                                  2009    2008[1]       2009      2008[1]
                                  ----    -------       ----      -------

    Revenues:
        Premium               $1,298,969 $1,080,367 $3,801,306    $3,228,727
        Investment income
         and other                 5,315     17,624     24,179        58,696
                                   -----     ------     ------        ------
            Total revenues     1,304,284  1,097,991  3,825,485     3,287,423
                               ---------  ---------  ---------     ---------
    Expenses:
        Health benefits        1,136,391    885,774  3,258,907     2,672,166
        Selling, general and
         administrative           82,238    112,222    288,898       332,104
        Premium taxes             38,336     23,906    101,077        68,051
        Litigation
         settlement                    -          -          -       234,205
        Depreciation and
         amortization              8,441      8,811     26,447        26,459
        Interest                   3,929      5,082     12,399        16,107
                                   -----      -----     ------        ------
            Total expenses     1,269,335  1,035,795  3,687,728     3,349,092
                               ---------  ---------  ---------     ---------
            Income (loss)
             before income
             taxes                34,949     62,196    137,757       (61,669)
    Income tax expense            12,400     24,270     28,700        30,800
                                  ------     ------     ------        ------
            Net income (loss)    $22,549    $37,926   $109,057      $(92,469)
                                 =======    =======   ========      ========


        Diluted net income
         (loss) per share          $0.43      $0.71      $2.07        $(1.75)
                                   =====      =====      =====        ======

        Weighted average
         number of common
         shares and dilutive
         potential common
         shares outstanding   51,920,745 53,494,690 52,754,511  52,914,156[2]
                              ========== ========== ==========  ============

    [1] 2008 results reflect the previously disclosed reclassification of
        premium taxes and experience rebate. Additionally, results include
        the impact from the adoption of a new accounting pronouncement related
        to convertible debt instruments which increased interest expense in
        each of the periods presented.
    [2] Weighted shares in the nine months ended September 30, 2008 exclude
        potentially dilutive common stock equivalents due to the net loss in
        that period in accordance with generally accepted accounting
        principles.



    The following table sets forth selected operating ratios.  All ratios,
    with the exception of the health benefits ratio, are shown as a
    percentage of total revenues.


                                           Three months    Nine months
                                               ended          ended
                                           September 30,  September 30,
                                           -------------  -------------
                                            2009   2008   2009   2008
                                            ----   ----   ----   ----
    Premium revenue                         99.6%  98.4%  99.4%  98.2%
    Investment income and other              0.4    1.6    0.6    1.8
                                             ---    ---    ---    ---
    Total revenues                         100.0% 100.0% 100.0% 100.0%
                                           =====  =====  =====  =====
    Health benefits [1]                     87.5%  82.0%  85.7%  82.8%
    Selling, general and administrative
     expenses                                6.3%  10.2%   7.6%  10.1%
    Income (loss) before income taxes        2.7%   5.7%   3.6%  (1.9)%
    Net income (loss)                        1.7%   3.5%   2.9%  (2.8)%

    [1] The health benefits ratio is shown as a percentage of premium revenue
        because there is a direct relationship between the premium received
        and the health benefits provided.



    The following table sets forth the approximate number of members the
    Company served in each state as of September 30, 2009 and 2008.  Because
    the Company receives two premiums for members that are in both the
    Medicare Advantage and Medicaid products, these members have been counted
    twice in the states where the Company offers both plans.

                               September 30,
                               -------------
                               2009      2008
                               ----      ----
        Texas[1]              498,000   462,000
        Florida               270,000   228,000
        Georgia               236,000   201,000
        Tennessee[2]          192,000   352,000
        Maryland              188,000   161,000
        New Jersey            117,000   103,000
        New York              112,000   111,000
        Ohio                   59,000    56,000
        Nevada                 56,000         -
        Virginia               30,000    24,000
        New Mexico             20,000     7,000
        South Carolina[3]           -     9,000
                                  ---     -----
              Total         1,778,000 1,714,000
                            ========= =========

    [1] Membership includes approximately 13,000 under an ASO contract in
        2009.
    [2] Membership includes approximately 165,000 under an ASO contract in
        2008 terminated on October 31, 2008.
    [3] AMERIGROUP exited the State of South Carolina on March 1, 2009.



    The following table sets forth the approximate number of members in each
    of the Company's products as of September 30, 2009 and 2008.  Because the
    Company receives two premiums for members that are in both the Medicare
    Advantage and Medicaid products, these members have been counted in each
    product.

                                   September 30,
                                   -------------
        Product                    2009      2008
        -------                    ----      ----
        TANF (Medicaid)[1][3]   1,245,000 1,205,000
        CHIP[3]                   259,000   241,000
        ABD (Medicaid)[2]         202,000   218,000
        FamilyCare (Medicaid)      58,000    41,000
        Medicare Advantage         14,000     9,000
                                   ------     -----
        Total                   1,778,000 1,714,000
                                ========= =========


    [1] Membership includes approximately 124,000 members under an ASO
        contract in 2008 terminated on October 31, 2008.
    [2] Membership includes approximately 13,000 ASO members in 2009 and
        41,000 members  under an ASO contract in 2008 terminated on October
        31, 2008.
    [3] 2008 reflects a reclassification from CHIP to TANF to coincide with
        State classifications.



                  AMERIGROUP CORPORATION AND SUBSIDIARIES
                   CONDENSED CONSOLIDATED BALANCE SHEETS
               (dollars in thousands, except per share data)
                                (unaudited)

                                          September 30,     December 31,
                                               2009             2008
                                               ----             ----
                   Assets
    Current assets:
        Cash and cash equivalents            $516,190         $763,272
        Short-term investments                121,723           97,466
        Premium receivables                    87,458           86,595
        Deferred income taxes                  23,290           25,347
        Prepaid expenses,
         provider and other
         receivables and other                 70,376           42,281
                                               ------           ------
          Total current assets                819,037        1,014,961


    Property, equipment and
     software, net                            101,133          103,747

    Goodwill and other intangible
     assets, net                              249,878          250,205
    Long-term investments, including
     investments on deposit for
     licensure                                789,905          571,663
    Other long-term assets                     14,100           15,091
                                               ------           ------
                                           $1,974,053       $1,955,667
                                           ==========       ==========

                      Liabilities and
                    Stockholders' Equity
    Current liabilities:
        Claims payable                       $550,112         $536,107
        Unearned revenue                       66,107           82,588
        Accounts payable                        3,115            6,810
        Accrued expenses and other            162,338          170,811
        Current portion of long-
         term debt                                  -              506
                                                  ---              ---
          Total current liabilities           781,672          796,822

    Long-term debt                            232,610          268,956
    Other long-term liabilities                17,889           17,230
                                               ------           ------
          Total liabilities                 1,032,171        1,083,008
                                            ---------        ---------

    Stockholders' equity:
        Common stock, $.01 par value              543              539
        Additional paid-in
         capital, net of
         treasury stock                       388,702          434,789
        Accumulated other comprehensive
         income (loss)                          2,227           (4,022)
        Retained earnings                     550,410          441,353
                                              -------          -------
          Total stockholders' equity          941,882          872,659
                                              -------          -------
                                           $1,974,053       $1,955,667
                                           ==========       ==========



                      AMERIGROUP CORPORATION AND SUBSIDIARIES
                  CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                                    (unaudited)
                                                          Nine months ended
                                                            September 30,
                                                            -------------
                                                            2009      2008
                                                            ----      ----
                                                        (dollars in thousands)
    Cash flows from operating
     activities:
      Net income (loss)                                   $109,057  $(92,469)
      Adjustments to reconcile net
       income (loss) to net cash
       provided by
       (used in) operating
       activities:
        Depreciation and
         amortization                                       26,447    26,459
        Loss on disposal of property,
         equipment and software                                289       442
        Deferred tax expense
         (benefit)                                           2,481    (2,364)
        Compensation expense related
         to share-based payments                            12,034     7,702
        Convertible debt non-cash
         interest expense                                    7,480     7,008
        Other                                                 (326)    8,808
        Gain on sale of contract
         rights                                             (5,810)        -
        Changes in assets and
         liabilities (decreasing)
         increasing cash flows
         from operations:
          Premium receivables                                 (863)   10,480
          Prepaid expenses, provider
           and other receivables and
           other current assets                            (26,534)   27,781
          Other assets                                      (1,146)     (942)
          Claims payable                                    14,005   (13,131)
          Unearned revenue                                 (16,481)  (14,394)
          Accounts payable, accrued
           expenses and other current
           liabilities                                     (10,245)    5,342
          Other long-term liabilities                       (3,793)      (98)
                                                            ------       ---
                          Net cash
                           provided by
                           (used in)
                           operating
                           activities                      106,595   (29,376)
                                                           -------   -------

    Cash flows from investing
     activities:
      Release of restricted
       investments held as
       collateral                                                -   351,318
      (Purchase of) proceeds
       from sale of
       investments, net                                   (221,987)    2,332
      Purchase of investments on
       deposit for licensure, net                           (9,901)   (4,557)
      Purchase of property,
       equipment and software                              (21,680)  (27,547)
      Proceeds from sale of
       contract rights                                       5,810         -
                                                             -----       ---
                          Net cash
                           (used in)
                           provided by
                           investing
                           activities                     (247,758)  321,546
                                                          --------   -------

    Cash flows from financing
     activities:
      Repayments of
       borrowings under
       credit facility                                     (44,318)  (79,025)
      Payment of capital lease
       obligations                                               -      (357)
      Proceeds and tax benefits
       from exercise of stock
       options and change
       in bank overdrafts and
       other, net                                            1,227     7,344
      Treasury stock repurchases                           (62,828)  (22,890)
                                                           -------   -------
                          Net cash used
                           in financing
                           activities                     (105,919)  (94,928)
                                                          --------   -------
    Net (decrease) increase
     in cash and cash
     equivalents                                          (247,082)  197,242
    Cash and cash equivalents at
     beginning of period                                   763,272   487,614
                                                           -------   -------
    Cash and cash equivalents
     at end of period                                     $516,190  $684,856
                                                          ========  ========



                  AMERIGROUP CORPORATION AND SUBSIDIARIES
             Components of the Change in Medical Claims Payable
                           (dollars in thousands)

                                          Nine months   Twelve months
                                              ended          ended
                                           September       December
                                            30, 2009       31, 2008
                                           ----------      ---------
    Medical claims payable, beginning
     of period                                $536,107        $541,173

    Health benefits expenses incurred
     during period:
        Related to current year              3,348,701       3,679,107
        Related to prior years                 (89,794)        (60,846)
                                               -------         -------
            Total incurred                   3,258,907       3,618,261
                                             ---------       ---------

    Health benefits payments during
     period:
        Related to current year              2,847,217       3,197,732
        Related to prior years                 397,685         425,595
                                               -------         -------
            Total payments                   3,244,902       3,623,327
                                             ---------       ---------

    Medical claims payable, end of period     $550,112        $536,107
                                              ========        ========


    Health benefits expenses incurred during both periods were reduced for
    mounts related to prior years.  The amounts related to prior years
    include the impact of amounts previously included in the liability to
    establish it at a level sufficient under moderately adverse conditions
    that were not needed and the reduction in health benefits expense due to
    revisions to prior estimates.  The amount related to the prior year for
    the period ended September 30, 2009 also included the one-time impact of
    establishing estimates for pharmacy rebates which began in the first
    quarter of 2009.
    CONTACTS:
    Investors:  Julie Loftus Trudell              Media: Tara Wall
    Senior Vice President, Investor Relations     Senior Vice President,
                                                   Communications
    AMERIGROUP Corporation                        AMERIGROUP Corporation
    (757) 321-3597                                (757) 518-3671

SOURCE AMERIGROUP Corporation


'/>"/>
SOURCE AMERIGROUP Corporation
Copyright©2009 PR Newswire.
All rights reserved


Related medicine news :

1. AMERIGROUP Announces Preliminary Third Quarter Results
2. AMERIGROUP Corporation to Discuss Third Quarter Earnings on October 30
3. AMERIGROUP Corporation Names Two New Executives
4. AMERIGROUP Corporation to Host Investor Day
5. AMERIGROUP Foundation Honors Warehouse of Hope Founder Craig Parson as a Healthy Hero
6. AMERIGROUP Reports Q2 Net Income of $49.6 Million or $0.94 per Diluted Share, Including $0.43 per Diluted Share Positive Impact from Tax Adjustment
7. AMERIGROUP Public Policy Institute, Black Leadership Forum, Inc. Convene Summit to Examine Preterm Birth Policy Solutions
8. AMERIGROUP Corporation to Discuss Second Quarter Earnings on July 31
9. AMERIGROUP Corporation to Present at the 19th Annual Wachovia Mid-Year Equity Conference on June 24
10. Dr. Emily Abrams Massey of Atlanta Honored as Healthy Hero by the AMERIGROUP Foundation
11. AMERIGROUP Corporation to Present at The Deutsche Bank 34th Annual Healthcare Conference on May 18
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... Altamonte Springs, FL (PRWEB) , ... February 09, ... ... nation’s leading innovative specialty pharmacies, announces today the continuation of the ‘Pay It ... donations for each prescription referral received at our specialty pharmacy. , “Since ...
(Date:2/9/2016)... ... February 09, 2016 , ... Dr. Rassouli, cosmetic dentist in Orange ... among the most popular cosmetic procedures in dentistry today, but the cost often leads ... them at risk of teeth whitening-related damage. For a limited time, Dr. Rassouli is ...
(Date:2/9/2016)... ... ... United Methodist Communications collaborated with Chocolate Moose Media and ... designed to prevent the next widespread Ebola outbreak from occurring in West ... Togo, Liberia, Sierra Leone, Nigeria, Côte d’Ivoire and other African countries, with additional ...
(Date:2/8/2016)... ... 2016 , ... CURE Media Group , the nation’s leading digital and ... Heroes Awards event , which will annually honor individuals making heroic contributions in the ... MM Heroes Awards nomination process is officially open through February 17 for ...
(Date:2/8/2016)... Texas (PRWEB) , ... February 08, 2016 , ... The Valentine’s Season is famous for ... members and significant others that they are loved. This year, for more than 5.6 ... they cost - just won't be enough to remind them of the lives they’ve led ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)...  Landauer, Inc. (NYSE: LDR ), a recognized ... outsourced medical physics services and high quality medical consumable ... first quarter ended December 31, 2015. ... Quarter Highlights , Revenue of $36.5 million compared ... , Domestic Radiation Measurement services revenues increased 2.8% year-over-year ...
(Date:2/9/2016)... Calif., Feb. 9, 2016  Sangamo BioSciences, Inc. ... genome editing, today reported its fourth quarter and ... in vivo therapeutic genome editing," said ... "Our zinc finger nuclease (ZFN) technology leads the ... the core competencies necessary to move our ground-breaking ...
(Date:2/9/2016)... , February 9, 2016 ... a collaboration with 10x Genomics to develop and ... biology and bioinformatics. --> QGEN ; ... with 10x Genomics to develop and promote comprehensive ... bioinformatics. --> QIAGEN N.V. (NASDAQ: ...
Breaking Medicine Technology: